Clal Biotechnology (Israel) Story

CBI Stock   46.40  1.60  3.57%   
About 55% of Clal Biotechnology's investors are presently thinking to get in. The analysis of current outlook of investing in Clal Biotechnology Industries suggests that some traders are interested regarding Clal Biotechnology's prospects. Clal Biotechnology's investor sentiment overview provides quick insight into current market opportunities from investing in Clal Biotechnology Industries. The current market sentiment, together with Clal Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Clal Biotechnology stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Clal Biotechnology stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Clal daily returns and investor perception about the current price of Clal Biotechnology Industries as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Clal Biotechnology Industries.

Clal Biotechnology Latest Timeline

Clal Biotechnology is currently traded for 46.40on Tel Aviv Stock Exchange of Israel. About 65.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Clal Biotechnology recorded a loss per share of 0.57. The entity last dividend was issued on the 29th of March 2021.
Check out Clal Biotechnology Hype Analysis, Clal Biotechnology Correlation and Clal Biotechnology Performance.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Clal Stock analysis

When running Clal Biotechnology's price analysis, check to measure Clal Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clal Biotechnology is operating at the current time. Most of Clal Biotechnology's value examination focuses on studying past and present price action to predict the probability of Clal Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clal Biotechnology's price. Additionally, you may evaluate how the addition of Clal Biotechnology to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Please note, there is a significant difference between Clal Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clal Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clal Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.